Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02435342 |
|---|---|
| Brief Title: | A 4 Week Study of the Safety, Tolerability, and Pharmacodynamics of ShK-186 (Dalazatide) in Active Plaque Psoriasis |
| First Submitted : | April 15, 2015 |
| First Submitted that Met QC Criteria : | May 1, 2015 |
| First Posted : | May 6, 2015 (Estimate) |
| Last Update Submitted that Met QC Criteria : | May 1, 2015 |
| Last Update Posted : | May 6, 2015 (Estimate) |